Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis

    NEXT STORY
    Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
    PREV STORY
    Point of Care Testing Market Size Worth USD 38.40billion by 2026: Acumen Research And Consulting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Clinical Nutrition Market Will Reach USD 61.44 Billion by 2023: Zion Market Research

    New York, NY, March 12, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published ...

    author_avatar
    NASDAQ Market News

    Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions

    Approximately 98% of patients receiving highest dose achieved reductions in Lp(a) levels below the ...

    author_avatar
    NASDAQ Market News

    Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023

    GAITHERSBURG, Md., Jan. 29, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine ...

    author_avatar
    NASDAQ Market News